Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07675460Completed
Open-label, single-arm trial of isotretinoin in acne vulgaris. Primary endpoint: Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v4.0 at 24 weeks. Started Apr 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07675460.